Topics
Meeting category
Date(s)
1 Dec 2023 - 2 Dec 2023
Program Language
English
Location
Amsterdam,
Netherlands
Meeting type
Hybrid Meeting
CME Credits: 7.5
Meeting Organizers
Co-Convener
Sponsor logos
International Viral Hepatitis Elimination Meeting (IVHEM) 2023
Related Enduring Materials
Enduring Materials
Virtual Program Book IVHEM 2023
Virtual Abstract Book IVHEM 2023
Friday, 1 December 2023
Session 1: Hepatitis Elimination - Where Do We Stand? -
Mohamed Hassany, M.B.BCh., M.Sc., M.D.
John Ward, MD
1:15 PM
Progress Towards Hepatitis Elimination: WHO Perspective
1:25 PM
Egypt's National Program on Hepatitis Elimination
National Hepatology and Tropical Medicine Research Institute (NHTMRI), Egypt
1:35 PM
Pakistan's National Program on Hepatitis Elimination
1:40 PM
Ukraine's National Program on Hepatitis Elimination
1:45 PM
Commission & Coalition Report
Coalition for Global Hepatitis Elimination, Task Force for Global Health / Rollins School of Public Health, Emory University, United States
Session 2: New HBV Treatment Guidelines: Expanding the Access to Achieve 2030 Targets -
3:05 PM
Update on New WHO Treatment Guidelines
3:20 PM
Towards an Expanded Access: New HBV Treatment Guidelines in China
3:35 PM
Stigma Reducing/Elimination Program led by Community
3:50 PM
The Gambia's Regional Perspectives on Implementation Challenges
3:53 PM
Spain's Regional Perspectives on Implementation Challenges
3:56 PM
The Western Pacific's Regional Perspectives on Implementation Challenges
Day 1 Closing Lecture: When Two Epidemics Collide -
5:00 PM
Reducing Harm and Integrating Care For HIV and Viral Hepatitis
Saturday, 2 December 2023
Session 3: New Tools for Diagnostics & Monitoring to Tackle Long-Standing Challenges -
9:00 AM
Self-Testing for HCV: Lessons Learned from Implementation Pilots
9:15 AM
New Biomarkers and Core Antigen-Based Tests for HBV
Session 4: Prevention -
10:45 AM
Birth Dose of HBV Vaccine
11:00 AM
Hep D - Disease Burden, Screening, Preventing Disease Progression
11:15 AM
Oral Abstract Presentation #4: Integration of Hepatitis B Screening and Management in Antenatal Services: A Comprehensive Approach to Prevent Mother-To-Child Transmission
Session 5: Innovations in Service Delivery -
Naveed Zafar Janjua, MBBS, MSc, DrPH
Gamal Shiha, MB BCh, M.SC, MD
1:00 PM
HCV Care Beyond the Cure
BC Centre for Disease Control / School of Population & Public Health, University of British Columbia, Canada
1:15 PM
Delivering Care in Remote Communities - Sharing a Successful Example
Faculty of Medicine, Mansoura University / Egyptian Liver Research Institute and Hospital (ELRIAH), Egypt
Panel Discussion: Joining the Forces to Eliminate Viral Hepatitis - How to Strengthen Collaboration? -
John Ward, MD
Samir Desai, B.Sc., MA, M Phil, Executive Management Program- IIM Ahmedabad
Christophe Martinaud, MD, PhD
Chair:
Coalition for Global Hepatitis Elimination, Task Force for Global Health / Rollins School of Public Health, Emory University, United States
2:20 PM
Panelist:
Zydus Lifesciences Limited, India
Medical Director - Medical & Scientific Affairs Europe, Middle East & Africa, Cepheid, France
General
Welcome
The International Viral Hepatitis Elimination Meeting (IVHEM) 2023 took place as a hybrid meeting from 1 to 2 December 2023 in Amsterdam, the Netherlands!
Convened by Academic Medical Education and the Coalition for Global Hepatitis Elimination (CGHE), IVHEM is a global forum for the exchange of practical experiences for translating diagnostic and therapy advances of viral hepatitis into broad applications that accelerate progress towards the elimination of viral hepatitis as a public health threat by 2030.
Hepatitis B and C affect more than 354 million people globally and can lead to liver disease and mortality from liver failure and hepatocellular carcinoma. More than 296 million people (3.7% of the world’s population) live with HBV, and over 820,000 deaths are attributable annually. An estimated 58 million people (globally, 0.73%) live with the hepatitis C virus (HCV), resulting in nearly 290,000 deaths annually.
Key issues addressed were how to translate research outcomes into public health policy and practice to meet the 2030 elimination targets. During this two-day meeting, experts in viral hepatitis from around the globe examined current evidence on how to implement programs that improve the prevention of viral hepatitis and increase the number of people accessing testing and treatment.
The program included practical examples of innovative intervention studies, country elimination programs, and novel funding mechanisms for testing and treatment.
The Organizing Committee
Program Chairs 2023
Organizers
IVHEM is convened by Academic Medical Education and the Coalition for Global Hepatitis Elimination (CGHE).
General Information
Venue
The confirmed venue for IVHEM 2023 was at the following location:
Amsterdam Marriott Hotel
Stadhouderskade 12
1054 ES Amsterdam
The Netherlands
Distance from Amsterdam Airport Schiphol: 14.6 km
Amsterdam Marriott Hotel
Stadhouderskade 12
1054 ES Amsterdam
The Netherlands
Distance from Amsterdam Airport Schiphol: 14.6 km
Accommodation
No accommodation was provided or included in the registration fees. The proposed accommodation at the Amsterdam Marriott Hotel was only a recommendation as the meeting took place in the same hotel venue.
Networking Dinner
The networking dinner took place at Umami by Han, Amsterdam, the Netherlands.
Dinner venue: Umami by Han Amsterdam
Address: Overtoom 31HS, 1054 HB Amsterdam, the Netherlands.
Website: https://umami-restaurant.com/
Distance from the hotel venue: 250 m (3-min walking distance)
Dinner venue: Umami by Han Amsterdam
Address: Overtoom 31HS, 1054 HB Amsterdam, the Netherlands.
Website: https://umami-restaurant.com/
Distance from the hotel venue: 250 m (3-min walking distance)
COVID-19 Update
Responding to the changing COVID-19 situation, the International Viral Hepatitis Elimination Meeting (IVHEM) 2023 will be held as a hybrid meeting. This workshop format is an optimal solution in light of the current circumstances.
We are available to answer any questions or concerns that you may have about your participation. For more information, please contact Michelle Wu via Michelle.Wu@amededu.com
We are available to answer any questions or concerns that you may have about your participation. For more information, please contact Michelle Wu via Michelle.Wu@amededu.com
Who Should Attend?
- Healthcare professionals
- Clinicians
- Researchers
- Policymakers
- Virologists
- Pharmacologists
- Industry representatives
- Community representatives
- Clinicians
- Researchers
- Policymakers
- Virologists
- Pharmacologists
- Industry representatives
- Community representatives
Meeting Objectives
This meeting aimed to:
- Provide a forum for knowledge exchange and discussion of practical experiences related to the clinical management of viral hepatitis;
- Provide a toolbox for the practical application of research & development for evidence-based policymaking; and
- Facilitate cross-disciplinary discussion on barriers and challenges preventing the elimination of viral hepatitis.
- Provide a forum for knowledge exchange and discussion of practical experiences related to the clinical management of viral hepatitis;
- Provide a toolbox for the practical application of research & development for evidence-based policymaking; and
- Facilitate cross-disciplinary discussion on barriers and challenges preventing the elimination of viral hepatitis.
Learning Objectives
After participating in this activity, participants are able to:
- Identify innovative strategies for hepatitis b and hepatitis C testing and linkage to care and how these can be applied to their program and clinical activities;
- Recognize the needs from a public health perspective and respond to these needs by reshaping their policymaking approaches;
- Further develop new or strengthen already existing foundations for political commitment, national planning, and program improvements; and
- Translate the latest research and technologies into clinical policy and practice for delivering an adequate continuum of viral hepatitis services.
- Identify innovative strategies for hepatitis b and hepatitis C testing and linkage to care and how these can be applied to their program and clinical activities;
- Recognize the needs from a public health perspective and respond to these needs by reshaping their policymaking approaches;
- Further develop new or strengthen already existing foundations for political commitment, national planning, and program improvements; and
- Translate the latest research and technologies into clinical policy and practice for delivering an adequate continuum of viral hepatitis services.
Practical Information
Ethical MedTech
We are glad to inform that the European Meeting on HIV & Hepatitis 2023 has received COMPLIANT status from Ethical MedTech Europe platform.
For more information, you can visit the website of Ethical MedTech EU with the following link: https://www.ethicalmedtech.eu/
For more information, you can visit the website of Ethical MedTech EU with the following link: https://www.ethicalmedtech.eu/
Certificate of Attendance
A certificate of attendance will be sent to participants who successfully complete the meeting and post-meeting survey.
Language
The official language of the workshop is English.
Translation will not be provided.
Translation will not be provided.
Enduring Materials
Enduring materials will be available here shortly after the conclusion of the meeting.
Disclaimer
This meeting was intended for educational purposes only and aims to offer participants the opportunity to share information. The Organizing Secretariat of this meeting, AME, cannot accept any liability for the scientific content of the sessions or for any claims which may result from the use of information or publications from this meeting. AME disclaims all liability for injuries or losses of whatever nature incurred by individuals attending the meeting.
Liability and Insurance
By registering for the meeting, participants agree that the organizers do not accept responsibility for medical-, travel- or personal insurance. Participants are advised to take out their own insurance policies
Photographs, Audio, and Video Recording
Photographs, audio, and video recordings were not permitted at the official meeting sessions. Only the official medical writer appointed by the organization may make recordings. All presentations will be posted here as soon as possible after the meeting is finished, provided that the speaker has given permission to do so.
Code of Conduct
All attendees, speakers, co-organizers, partners, endorsers, suppliers, volunteers, and employees at any of our programs are expected to observe our Code of Conduct. We cannot tolerate any form of discrimination, harassment, disrespect, or the marginalization of those involved in our programs. All participants of AME-organized programs are expected to treat others with dignity and respect at all times.
Any individual who feels discriminated against, harassed, disrespected, or marginalized is encouraged to report the incident(s) to AME via info@amededu.com or to one of our on-site personnel.
Any participant who is found to have exhibited any inappropriate conduct or behavior against others may be removed from the program.
Any individual who feels discriminated against, harassed, disrespected, or marginalized is encouraged to report the incident(s) to AME via info@amededu.com or to one of our on-site personnel.
Any participant who is found to have exhibited any inappropriate conduct or behavior against others may be removed from the program.
Registration
Please check this website or subscribe to our newsletter for the latest updates.
Fees and Conditions
|
Regular Delegates - In Person |
Regular Delegates - Virtual |
Industry |
|
|---|---|---|---|
|
Early Fee (payment before/on 1 March 2023) |
€295 |
€147.50 |
€795 |
|
Standard Fee (payment before/on 30 November 2023) |
€695 |
€347.50 |
€1195 |
|
Same Day Fee (payment from 1 December 2023) |
€895 |
€447.50 |
€1395 |
|
Discounts |
|
|---|---|
|
Early-Career Investigators / Regular Delegates from Resource-Limited Settings (RLS)* WITH an accepted abstract |
Complimentary Registration |
|
Early-Career Investigators / Regular Delegates from Resource-Limited Settings (RLS)* WITHOUT an accepted abstract |
50% Off Current Regular Delegates Fee |
|
NGO Representatives / Government Representatives (i.e. MOH, NIH, NIAID, etc.) / Advocates |
50% Off Current Regular Delegates Fee |
|
Members of Endorsers |
25% Off Current Regular Delegates Fee |
|
Sponsors |
Contact Secretariat |
If eligible for a discount, please contact the conference secretariat via Michelle Wu via Michelle.Wu@amededu.com for the special registration code.
*Countries included in the low-income and middle-income economies list of the World Bank Classification
Important
-
We strongly advise that you register early to ensure that your registration is secured.
-
Submission of your online registration does not guarantee that your registration has been accepted. Your registration is final when full prepayment has been received and a confirmation of your registration has been sent.
-
No day rate is available.
Registration Fee Includes
For onsite attendees:
- Access to all scientific sessions, including poster area;
- Meeting pack, including digital abstract book and printed program book;
- Refreshments during the coffee breaks;
- Buffet lunch on meeting days;
- Complimentary entrance to the Networking Reception*
- Access to all enduring materials
* The Networking Reception will take place in the same venue of the meeting, at Amsterdam Marriott Hotel, and will not have any music / entertainment of any shape or form. The Networking Reception only offers finger foods and the opportunity to have a look at the chosen abstract poster presentations.
For virtual attendees only:
- Access to all scientific sessions
- Digital meeting pack, including the digital abstract book and program book
- Access to all enduring materials
IMPORTANT:
- No day rate is available
- The Networking Dinner is not included in the registration fee. Should you wish to attend the Networking Dinner, an additional fee of €60 is charged. Pre-booking is required via the conference secretariat.
- Academic Medical Education reserves the right to cancel improper registrations. Claims for a refund will not be honored.
- Access to all scientific sessions, including poster area;
- Meeting pack, including digital abstract book and printed program book;
- Refreshments during the coffee breaks;
- Buffet lunch on meeting days;
- Complimentary entrance to the Networking Reception*
- Access to all enduring materials
* The Networking Reception will take place in the same venue of the meeting, at Amsterdam Marriott Hotel, and will not have any music / entertainment of any shape or form. The Networking Reception only offers finger foods and the opportunity to have a look at the chosen abstract poster presentations.
For virtual attendees only:
- Access to all scientific sessions
- Digital meeting pack, including the digital abstract book and program book
- Access to all enduring materials
IMPORTANT:
- No day rate is available
- The Networking Dinner is not included in the registration fee. Should you wish to attend the Networking Dinner, an additional fee of €60 is charged. Pre-booking is required via the conference secretariat.
- Academic Medical Education reserves the right to cancel improper registrations. Claims for a refund will not be honored.
Group Registration
For registration of groups larger than 5 participants, please contact Michelle Wu at Michelle.Wu@amededu.com to use the Group Registration Portal.
Regular Delegates from Resource-limited Settings (RLS) / Early-Career Investigators
We are pleased to waive the registration fee for early-career investigators and regular delegates from low-income and lower-middle-income countries with an accepted abstract and also provide a 50% discount on the registration fee for those without an accepted abstract.
IMPORTANT: the registration fee waiver is offered to the presenting author only.
To be eligible as a young investigator, one should either be:
a current Master/PhD student, or
have obtained an MD/PharmD/PhD degree in the last five years.
An application form (available below) needs to be completed by a supervisor and received by the secretariat at least two weeks prior to the start of the workshop. AME and VE will contact the investigator with instructions regarding the registration procedure.
IMPORTANT: the registration fee waiver is offered to the presenting author only.
To be eligible as a young investigator, one should either be:
a current Master/PhD student, or
have obtained an MD/PharmD/PhD degree in the last five years.
An application form (available below) needs to be completed by a supervisor and received by the secretariat at least two weeks prior to the start of the workshop. AME and VE will contact the investigator with instructions regarding the registration procedure.
Sponsored Attendance
If you are invited by a pharmaceutical or diagnostic company, or if your registration is organized by a travel agency, please do not register online. The sponsoring company will be asked to register you via the conference secretariat.
Payment
By credit card only: online or by written authorization.
Please contact Michelle Wu at Michelle.Wu@amededu.com if you need to make alternative arrangements.
Please contact Michelle Wu at Michelle.Wu@amededu.com if you need to make alternative arrangements.
Cancellation Policy
In case of cancellation, the following refunds are applicable:
- Cancellation before/on 30 November 2023: 50% refund (minus an administration fee of €40)
- Cancellation after 30 November 2023: Unfortunately, no refund will be given
If you are unable to attend the meeting, a substitute delegate is always welcome at no extra charge, provided that a letter of authorization from the original participant has been received and the conference secretariat has been notified of the name of the substitute delegate before 13 November 2023. A statement (email/letter) of cancellation must be sent to AME.
- Cancellation before/on 30 November 2023: 50% refund (minus an administration fee of €40)
- Cancellation after 30 November 2023: Unfortunately, no refund will be given
If you are unable to attend the meeting, a substitute delegate is always welcome at no extra charge, provided that a letter of authorization from the original participant has been received and the conference secretariat has been notified of the name of the substitute delegate before 13 November 2023. A statement (email/letter) of cancellation must be sent to AME.
Liability and Insurance
By registering for the meeting, participants agree that the organizers do not accept responsibility for medical, travel, or personal insurance. Participants are advised to take out their own insurance policies.
Media Registration
In order to register as a media participant for the meeting, the conference secretariat needs to receive:
1. Proof of accreditation
2. Valid identification (e.g. passport)
3. A letter from your assignment giver stating the details of your assignment (e.g. editor)
4. At least 3 previous written assignments in recognized outlets on Hepatitis. If you are a freelance journalist, the assignments can be from different (recognizable) news outlets. Links to online publications are accepted
5. The website of the publication(s)/blog(s) that will be featuring your story on this meeting
A free or reduced registration fee may apply for accredited media participants depending on availability. Preference will be given to credible print and online news sources. Please contact the conference secretariat for registration conditions.
We would like to receive a copy of your meeting report/ article once it is finalized.
All credentials will be verified by the Organizing Committee of the meeting. Media representatives are kindly requested to register by sending the above-mentioned information to info@amededu.com.
Important: Media is restricted to the written press. Recording on film or photo is not allowed. AME will request a copy of the written piece once it is finalized. Media representatives must also agree to abide by the 2023 embargo policy.
1. Proof of accreditation
2. Valid identification (e.g. passport)
3. A letter from your assignment giver stating the details of your assignment (e.g. editor)
4. At least 3 previous written assignments in recognized outlets on Hepatitis. If you are a freelance journalist, the assignments can be from different (recognizable) news outlets. Links to online publications are accepted
5. The website of the publication(s)/blog(s) that will be featuring your story on this meeting
A free or reduced registration fee may apply for accredited media participants depending on availability. Preference will be given to credible print and online news sources. Please contact the conference secretariat for registration conditions.
We would like to receive a copy of your meeting report/ article once it is finalized.
All credentials will be verified by the Organizing Committee of the meeting. Media representatives are kindly requested to register by sending the above-mentioned information to info@amededu.com.
Important: Media is restricted to the written press. Recording on film or photo is not allowed. AME will request a copy of the written piece once it is finalized. Media representatives must also agree to abide by the 2023 embargo policy.
Disclaimer
This meeting was intended for educational purposes only and aims to offer participants the opportunity to share information. The organizing secretariat of this meeting, AME, cannot accept any liability for the scientific content of the sessions or for any claims which may result from the use of information or publications from this meeting. AME disclaim all liability for injuries or losses of whatever nature incurred by individuals attending the meeting. In case of cancellation of the meeting due to unforeseen circumstances, AME cannot be held responsible for expenses made for travel, accommodation, visa applications, etc.
Downloads:
Abstracts
The abstract submission portal for IVHEM 2023 is closed
Abstracts
- The deadline for abstract(s) submission for IVHEM 2023 has passed.
- Registration fees were waived for healthcare professionals from RLS and early-career professionals with an accepted abstract. A 50% discount was offered to healthcare professionals from RLS and early-career professionals without an accepted abstract. The requirements for the application are specified under "Registration".
- IVHEM 2023 accepted new original data as well as encored abstracts. All abstracts must have focused on health care challenges related to the prevention and treatment of Hepatitis and contain up-to-date information at the time of the meeting.
-
Abstract submitters were strongly encouraged to use person-first language in their abstracts. View the video tutorial and guidelines here
Terms and Conditions
By submitting an abstract to a meeting organized by Academic Medical Education BV (AME), the abstract submitter hereby agrees to the terms and conditions.
The terms and conditions can be viewed here.
Categories for Abstract Submission
For purposes of review and programming, abstracts are divided into topical categories. The selection of the most appropriate category is important as it determines who reviews your abstract. The Organizing Committee reserves the right to reassign your abstract to a more appropriate category.
IVHEM accepts abstracts related to all viral hepatitis variants (HAV, HBV, HCV, HDV, and HEV) and coinfections. Abstracts can be submitted under the following categories:
- Assessing Progress Towards Hepatitis Elimination
- Hepatitis Micro-Elimination Programs
- Key Populations
- Model for Care
- Monitoring and Testing
- Prevention
- Strategies to Move Forward to Come to Elimination
IVHEM accepts abstracts related to all viral hepatitis variants (HAV, HBV, HCV, HDV, and HEV) and coinfections. Abstracts can be submitted under the following categories:
- Assessing Progress Towards Hepatitis Elimination
- Hepatitis Micro-Elimination Programs
- Key Populations
- Model for Care
- Monitoring and Testing
- Prevention
- Strategies to Move Forward to Come to Elimination
General Guidelines
Abstracts should contain the following four components:
- Background: A concise statement of the issue under investigation or a hypothesis;
- Material and Methods: The experimental methods used (including the statistical analyses employed);
- Results: Specific findings (promises such as "to be completed" or "to be presented" are not acceptable);
- Conclusions: A summary of findings that are supported by your results (statistical analyses used to support the conclusions, where appropriate, should be included; concluding statements such as "the results will be discussed" are not acceptable).
Please note that abstracts cannot be accepted if tables or graphs are included. The maximum word count for the abstract body is 500 words.
Abstracts are considered official communications to the meeting and will be treated confidentially. Submitters of accepted abstracts agree to attend the meeting and present their abstract as scheduled.
- Background: A concise statement of the issue under investigation or a hypothesis;
- Material and Methods: The experimental methods used (including the statistical analyses employed);
- Results: Specific findings (promises such as "to be completed" or "to be presented" are not acceptable);
- Conclusions: A summary of findings that are supported by your results (statistical analyses used to support the conclusions, where appropriate, should be included; concluding statements such as "the results will be discussed" are not acceptable).
Please note that abstracts cannot be accepted if tables or graphs are included. The maximum word count for the abstract body is 500 words.
Abstracts are considered official communications to the meeting and will be treated confidentially. Submitters of accepted abstracts agree to attend the meeting and present their abstract as scheduled.
Abstract Submission
Authors can submit their abstracts electronically. You will be redirected to the submission website. Please follow the step-by-step directions to upload the abstract. To ensure your abstract retains any special characters or formatting, the abstract must be in Microsoft Word format.
Poster Presentation Instructions for In Person Meeting
- Posters need to meet the following dimensions: A0 size (approx 33" width x 47" height), portrait format
- Poster presenters are requested to stand near their posters during the poster session.
- We advise you to prepare hand-outs of your poster on Letter or A4 format.
- Please hang your posters as early as possible. All posters must be displayed from the opening session to the closure of the meeting.
- Pushpins and/or tape will be provided.
- Poster presenters are requested to stand near their posters during the poster session.
- We advise you to prepare hand-outs of your poster on Letter or A4 format.
- Please hang your posters as early as possible. All posters must be displayed from the opening session to the closure of the meeting.
- Pushpins and/or tape will be provided.
Abstract Publication
Accepted abstracts will be published in the Abstract Book: The Journal Reviews in Antiviral Therapy & Infectious Diseases. This will be distributed during the meeting and will be available as enduring material after the meeting has concluded. Please note that the conference secretariat cannot be held responsible for any typing or language errors in the submitted abstracts as only the format of the abstracts will be changed and not the content.
AME is the sole copyright holder of the conference abstract book as a whole (also referred to as the Reviews in Antiviral Therapy & Infectious Diseases). The abstract authors will retain any and all copyright over their individual abstract. Information on copyright can be viewed in the abstract submission terms and conditions (see 'Terms and Conditions' above).
AME is the sole copyright holder of the conference abstract book as a whole (also referred to as the Reviews in Antiviral Therapy & Infectious Diseases). The abstract authors will retain any and all copyright over their individual abstract. Information on copyright can be viewed in the abstract submission terms and conditions (see 'Terms and Conditions' above).
Committees
Program Chairs
The members of the Organizing Committee are a group of carefully selected experts and inspirational leaders in their respective fields. They meet frequently to discuss the scientific program of the workshop, identify interesting topics and candidate speakers, and review all submitted abstracts.
Scientific Committee
- Rakesh Aggarwal, MD (AIIMS), DM (PGIMER), FNASc, FAMS - Jawaharlal Institute of Postgraduate Medical Education and Research (JIPMER), India
- Po-Lin Chan, MD - World Health Organization, Philippines
- Ponsiano Ocama, MD, PhD - Makerere University, Uganda
- Gagandeep Singh Grover, MD - Health and Family Welfare, India
- Saeed Hamid, MBBS, FRCP, FRCPI, FACP, FACG, FAASLD - Aga Khan University, Pakistan
- Angelos Hatzakis, MD, PhD, MSc - Athens University Medical School, Greece
- Margaret Hellard, AM, MBBS, FRACP, FAFPHM, PhD - Burnet Institute, Australia
- Khin Pyone Kyi, MBBS, DBact, MMedSc, PhD, FRCP - Myanmar Liver Foundation, Myanmar
- Jeffrey Lazarus, PhD, MIH, MA - Barcelona Institute for Global Health (ISGlobal), Spain
- Maud Lemoine, MD, PhD - Imperial College London, United Kingdom
- Liudmyla Maistat - Medicines Patent Pool, Switzerland
- Hailemichael Desalegn Mekonnen, MD, PhD - St. Paul’s Hospital Millennium Medical College, Ethiopia
- Yvonne Nartey, MBChB, MSc, MPhil – Cape Coast Teaching Hospital, Ghana
- Michael Ninburg, Hepatitis Education Project (HEP), United States
- Jean-Michel Pawlotsky, MD, PhD - Hôpital Henri Mondor, France
- Homie Razavi, PhD, MBA - Center for Disease Analysis (CDA), United States
- Shiv. K. Sarin, MD, DM, DSc. (Hony.), FNA, FNAS - Institute of Liver and Biliary Sciences (ILBS), India
- Janvier Serumondo, MD - Rwanda Biomedical Centre, Rwanda
-
Mark Sonderup, B Pharm, MBChB, FCP(SA), MMed - University of Cape Town, South Africa
-
Sonjelle Shilton, MPH - Foundation for Innovative New Diagnostics (FIND), Switzerland
-
Nasamon Wanlapakorn, MD, PhD - Chulalongkorn University, Thailand
The members of Scientific Committee are hand-picked by the Organizing Committee and the workshop secretariat based on their significant contributions and commitment to the field. They assist the Organizing Committee by providing them with suggestions for speakers and topics. In addition, members of the Scientific Committee participate in reviewing submitted abstracts, and play an active role during the workshop as moderators and/or chairs of sessions.
Support
Gold Level
Supported by Gilead who provided funding. Gilead has had no input into the content of the materials used at this meeting/conference.
Support Our Initiative
Financial backing to the International Viral Hepatitis Elimination Meeting (IVHEM) 2023 helps us deliver an impactful meeting experience for the benefit of healthcare professionals and community representatives involved in the elimination of viral hepatitis.
This collaboration plays a vital role in both the organizational as well as scientific success of the program.
To show your commitment to the cause and get in touch with us for a tailored support package, please contact Jesper Niesen at Jesper.Niesen@amededu.com or call +31 30 230 7140.
Benefits of Support
By supporting this program, we can offer the following advantages for your company.* Please contact us for the most recent support level benefits for this program.
- Symposium opportunities
- Verbal acknowledgment during the program
- Discounted and complimentary registrations for your representatives
- Company acknowledgment on digital meeting materials including but not limited to newsletters, flyers, program book, the streaming platform, and our website
- Digital advertising opportunities
- Social media shout-outs
- Logo on the digital conference bag
- Exhibition
*Subject to the support level
Downloads:
Partners
Endorsers
Media Partners
Accreditation
EACCME® Accreditation
The International Viral Hepatitis Elimination Meeting (IVHEM) 2023, Amsterdam, Netherlands, 01/12/2023-02/12/2023 organized by Virology Education B.V. has been accredited by the European Accreditation Council for Continuing Medical Education (EACCME®) with 7.5 European CME credits (ECMEC®s). Each medical specialist should claim only those credits that he/she actually spent in the educational activity.
Through an agreement between the European Union of Medical Specialists and the American Medical Association, physicians may convert EACCME® credits to an equivalent number of AMA PRA Category 1 Credits™. Information on the process to convert EACCME® credits to AMA credits can be found at https://edhub.ama-assn.org/pages/applications.
Live educational activities occurring outside of Canada, recognised by the UEMS-EACCME® for ECMEC® credits are deemed to be Accredited Group Learning Activities (Section 1) as defined by the Maintenance of Certification Program of the Royal College of Physicians and Surgeons of Canada.
Media
Invitation to Join IVHEM 2023
The Program Chairs, Dr. Huma Qureshi and Dr. John Ward, invite you to join IVHEM 2023 from 1 - 2 December.
Previous Editions
Top-Rated Materials from Previous Editions
A Whole Family Approach to HBV Prevention - Rangsima Lolekha, MD
IVHEM 2021
Language
Related Programs
